Area of research
Oncology · Epidemiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Multiple Myeloma Research and Treatments, Cancer Treatment and Pharmacology, and Fibroblast Growth Factor Research.
Head-to-head comparison of MASH resolution index versus FAST for noninvasive prediction of resolution of MASH on biopsy
MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASH
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
Zanubrutinib monotherapy for patients with treatment-naïve chronic lymphocytic leukemia and 17p deletion
Efficacy and Safety of Zanubrutinib in Patients with Treatment-Naïve (TN) Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) with del(17p): Follow-up Results from Arm C of the SEQUOIA (BGB-3111-304) Trial
Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study